Seres Therapeutics Announces Appointment of Eric D. Shaff to Additional Role of Chief Operating Officer

Published: 1/02/2018
Seres Therapeutics Announces Appointment of Eric D. Shaff to Additional Role of Chief Operating Officer
Source: WWW.BUSINESSWIRE.COM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., today announced the appointment of Eric D. Shaff to the additional role of Chief Operating Officer.

Read more
Related news
Comment